🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The blood brain barrier (BBB) prevents some drugs from successfully reachin...
Status
Recruiting
Location
Columbia University Irving Medical Center
Start Date
2023-06-05
Trial ID
NCT05762419
Treatments Being Tested
This research study is testing whether a weekly medication called tirzepati...
Status
Recruiting
Location
Institut de Recherches Cliniques de Montréal
Start Date
2026-05-19
Trial ID
NCT07284511
This is an observational, longitudinal, prospective study for sample collec...
Status
Active Not Recruiting
Location
Institute of Human Virology, University of Maryland School of Medicine
Start Date
2014-12
Trial ID
NCT02995252
The purpose of this study is to determine whether the addition of vitamin D...
Status
Withdrawn
Location
Imperial College Healthcare NHS Trust (Hammersmith, Charing Cross and St. Mary's Hospitals)
Start Date
2008-05
Trial ID
NCT00672763
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
This study will determine the effectiveness of three different drug therapi...
Status
Completed
Location
VA Palo Alto Health Care System
Start Date
2005-02
Trial ID
NCT00183443
Treatments Being Tested
The purpose of this research study is to find out what effects (good and ba...
Status
Completed
Location
Birmingham Hematology and Oncology
Start Date
2007-06
Trial ID
NCT00493649
Hepatocellular carcinoma (HCC) is a leading global cause of cancer-related ...
Status
Not Yet Recruiting
Location
Division of Hepato-Pancreato-Biliary Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2025-12-31
Trial ID
NCT07350824
Treatments Being Tested
Upadacitinib sustained-release tablets have not yet been approved for the t...
Status
Active Not Recruiting
Location
Tianjin Eye hospital
Start Date
2025-01-01
Trial ID
NCT07773623
Treatments Being Tested
This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2018-11-20
Trial ID
NCT02842125